PECAM1 and acute myeloid leukemia: During AML growth, in the leukemic BM niche, we observed a loss in CD31+Sca-1high ECs, which line mainly non-permeable arterioles, and a gain in CD31+Sca-1low ECs, which line mainly fenestrated, permeable sinusoids.